XML 43 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity (Tables)
 3 Months Ended
Mar. 31, 2018
Equity [Abstract]  
Equity
 
  
Common Stock
Other
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
 
Treasury Stock
Non-
Controlling
Interests
Total
($ and shares in millions)
Shares
Par Value
Shares
Cost
Balance at January 1, 2017
3,577

$
1,788

$
39,939

$
44,133

$
(5,226
)
828

$
(40,546
)
$
220

$
40,308

Net income attributable to Merck & Co., Inc.
—

—

—

1,551

—

—

—

—

1,551

Other comprehensive income, net of taxes
—

—

—

—

146

—

—

—

146

Cash dividends declared on common stock
—

—

—

(1,297
)
—

—

—

—

(1,297
)
Treasury stock shares purchased
—

—

—

—

—

16

(1,019
)
—

(1,019
)
Share-based compensation plans and other
—

—

(40
)
—

—

(7
)
408

—

368

Acquisition of Vallée
—

—

—

—

—

—

—

25

25

Net income attributable to noncontrolling interests
—

—

—

—

—

—

—

5

5

Other changes in noncontrolling ownership interests
—

—

—

—

—

—

—

1

1

Balance at March 31, 2017
3,577

$
1,788

$
39,899

$
44,387

$
(5,080
)
837

$
(41,157
)
$
251

$
40,088

Balance at January 1, 2018
3,577

$
1,788

$
39,902

$
41,350

$
(4,910
)
880

$
(43,794
)
$
233

$
34,569

Adoption of new accounting standards (see Note 1)
—

—

—

322

(274
)
—

—

—

48

Net income attributable to Merck & Co., Inc.
—

—

—

736

—

—

—

—

736

Other comprehensive income, net of taxes
—

—

—

—

124

—

—

—

124

Cash dividends declared on common stock
—

—

—

(1,301
)
—

—

—

—

(1,301
)
Treasury stock shares purchased
—

—

—

—

—

10

(566
)
—

(566
)
Share-based compensation plans and other
—

—

(28
)
—

—

(5
)
319

—

291

Net income attributable to noncontrolling interests
—

—

—

—

—

—

—

5

5

Distributions attributable to noncontrolling interests
—

—

—

—

—

—

—

(5
)
(5
)
Balance at March 31, 2018
3,577

$
1,788

$
39,874

$
41,107

$
(5,060
)
885

$
(44,041
)
$
233

$
33,901